EMA Withdrawn: Imprida (valsartan;amlodipine (as amlodipine besilate)) — Novartis Europharm Ltd

View source ↗

Summary

Imprida (valsartan; amlodipine) has been withdrawn from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Imprida (valsartan; amlodipine)

Snippet

Status: Withdrawn. Therapeutic area: Hypertension. MAH: Novartis Europharm Ltd. Decision date: 03/04/2017